These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 26325175

  • 1. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.
    Ceyhan M, Ozsurekci Y, Gürler N, Öksüz L, Aydemir S, Ozkan S, Yuksekkaya S, Keser Emiroglu M, Gültekin M, Yaman A, Kiremitci A, Yanık K, Karli A, Ozcinar H, Aydin F, Bayramoglu G, Zer Y, Gulay Z, Gayyurhan ED, Gül M, Özakın C, Güdücüoğlu H, Perçin D, Akpolat N, Ozturk C, Camcıoğlu Y, Karadağ Öncel E, Çelik M, Şanal L, Uslu H.
    Hum Vaccin Immunother; 2016; 12(2):308-13. PubMed ID: 26325175
    [Abstract] [Full Text] [Related]

  • 2. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 3. Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?
    Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indolfi G, Mattei R, Zuliani M, Adriani B, Degl'Innocenti R, Consales G, Aquilini D, Bini G, Di Natale ME, Canessa C, Ricci S, de Vitis E, Mangone G, Bechini A, Bonanni P, Pasinato A, Resti M.
    Hum Vaccin Immunother; 2016 Jan 15; 12(2):344-50. PubMed ID: 26647277
    [Abstract] [Full Text] [Related]

  • 4. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
    Wei SH, Chiang CS, Chiu CH, Chou P, Lin TY.
    Pediatr Infect Dis J; 2015 Mar 15; 34(3):e71-7. PubMed ID: 25247584
    [Abstract] [Full Text] [Related]

  • 5. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT, Cleary DW, Jefferies JM, Anderson R, Morris DE, Tuck AC, Gladstone RA, O'Doherty G, Kuruparan P, Bentley SD, Faust SN, Clarke SC.
    Vaccine; 2017 Mar 01; 35(9):1293-1298. PubMed ID: 28161425
    [Abstract] [Full Text] [Related]

  • 6. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A, Karabağ-Yılmaz E, Kepenekli E, Karaaslan A, Cagan E, Atıcı S, Atınkanat-Gelmez G, Boran P, Merdan S, Hasdemir U, Söyletir G, Bakır M.
    Vaccine; 2016 Jul 19; 34(33):3894-900. PubMed ID: 27269059
    [Abstract] [Full Text] [Related]

  • 7. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R, D'Ambrosio F, Del Grosso M, Pimentel de Araujo F, Caporali MG, Del Manso M, Gherardi G, D'Ancona F, Pantosti A, Pneumococcal Surveillance Group.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL, Minamisava R, Policena G, Cristo EB, Domingues CM, de Cunto Brandileone MC, Almeida SC, Toscano CM, Bierrenbach AL.
    Hum Vaccin Immunother; 2016 Aug 16; 12(2):285-92. PubMed ID: 26905679
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program.
    Miyazaki H, Shibuya R, Midorikawa N, Chang B, Ohnishi M, Matsumoto T.
    J Infect Chemother; 2017 Apr 16; 23(4):234-240. PubMed ID: 28161295
    [Abstract] [Full Text] [Related]

  • 14. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.
    Enferm Infecc Microbiol Clin; 2009 Jan 16; 27(1):14-21. PubMed ID: 19217998
    [Abstract] [Full Text] [Related]

  • 15. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC, Hsieh YC, Tsai MH, Lee CH, Kuo KC, Huang CT, Huang YC.
    J Microbiol Immunol Infect; 2018 Jun 16; 51(3):332-336. PubMed ID: 28082066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar 16; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.